TREA

79266012 - LETYBO

Follow

Information

  • Trademark
  • 79266012
  • Serial Number
    79266012
  • Registration Number
    6181983
  • Filing Date
    June 13, 2019
    6 years ago
  • Registration Date
    October 27, 2020
    5 years ago
  • Transaction Date
    February 26, 2025
    11 months ago
  • Status Date
    October 27, 2020
    5 years ago
  • Published for Opposition Date
    August 11, 2020
    5 years ago
  • Location Date
    April 11, 2024
    a year ago
  • Status Code
    700
  • Current Location
    TMO LAW OFFICE 115
    Employee Name
    MCMORROW, JANICE
  • Attorney Docket Number
    4150.0001
    Attorney Name
    James R Menker
    Law Office Assigned Location Code
    M60
  • Owners
Information
Mark Drawing Code
4
Mark Identification
LETYBO
Case File Statements
  • B00001: In statement Class 5, has been corrected per the F-note dated 4/11/2024.
  • GS0051: Pharmaceutical preparations for the treatment of spasm; pharmaceutical preparations for treating dystonia; muscle relaxants; pharmaceutical products for skin care for animals; pharmaceutical preparations used in cosmetic surgery; pharmaceutical preparations containing botulinum toxin; botulinum toxin for medical use for use in the treatment of neuropathy pain; pharmaceutical preparations containing botulinum toxin for the treatment of wrinkles; pharmaceutical preparations containing botulinum toxin fragments for the treatment of wrinkles; pharmaceutical preparations for use in treating urogenital system diseases and conditions, namely, overactive bladder and urinary incontinence; bacterial toxins, namely, bacterial poisons; pharmaceutical preparations for digestive system; pharmacological preparations for skin care; pharmaceutical preparations for treating peripheral neurological diseases and disorders; pharmaceutical preparations for treating central neurological diseases and disorders; ophthalmic preparations for use in the treatment of blepharospasm and strabismus; medicated ointments for treating dermatological conditions; chemical preparations for [ phamaceutical ] * pharmaceutical * purposes for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, wrinkles, hyperhydrosis and cerebral palsy; chemical preparations for [ phamaceutical ] * pharmaceutical * purposes for the treatment of sports injuries, namely, injured or torn skin, muscle, ligaments or bone; chemical preparations for [ phamaceutical ] * pharmaceutical * purposes for the treatment of tremors, namely, spasmodic smooth, striated or cardiac muscles; chemical preparations for [ phamaceutical ] * pharmaceutical * purposes for the treatment of pain, namely, smooth muscle pain, striated muscle pain, cardiac muscle pain, neuropathic pain, inflammatory pain, visceral pain, chronic pain, acute pain, traumatic injury pain, referred pain, growing pain, hunger pain, intractable pain, labour pain, organic pain, phantom limb pain, postprandial pain, psychogenic pain, back pain, post-stroke pain, cancer pain, nociceptive pain, headache pain, prostatic pain, and bladder pain; pharmaceutical agents for epidermis; drugs for medical purposes for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, wrinkles, hyperhydrosis and cerebral palsy; drugs for medical purposes for the treatment of sports injuries, namely, injured or torn skin, muscle, ligaments or bone; drugs for medical purposes for the treatment of tremors, namely, spasmodic smooth, striated or cardiac muscles; drugs for medical purposes for the treatment of pain, namely, smooth muscle pain, striated muscle pain, cardiac muscle pain, neuropathic pain, inflammatory pain, visceral pain, chronic pain, acute pain, traumatic injury pain, referred pain, growing pain, hunger pain, intractable pain, labour pain, organic pain, phantom limb pain, postprandial pain, psychogenic pain, back pain, post-stroke pain, cancer pain, nociceptive pain, headache pain, prostatic pain, and bladder pain; biological preparations for medical or veterinary purposes for the treatment of aesthetic dermatology, orthopaedics, arthritis and ophthalmology; cultures of microorganisms for medical or veterinary use; chemical reagents for medical or veterinary purposes; bacteriological preparations for medical and veterinary use; adjuvants for medical purposes; hyaluronic acid preparations for medical purposes; medicines for human purpose, namely, medicines for skin care; pharmaceutical preparations for the treatment of psychiatric diseases and disorders; pharmaceutical preparations for the treatment of orthopaedic disorders, namely, hip dislocation, spinal column deformation, curvature of the spine, namely, scoliosis, lordosis, cyphosis; pharmaceutical preparations for smooth muscle disorders, autonomic nerve disorders, headaches, hyperhydrosis, sports injuries, cerebral palsy, tremors and pain; pharmaceutical preparations for the treatment of wrinkles; injectable dermal filler; medicines for dental purposes; preparation for the relief of pain; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for treating skin disorders; pharmaceutical preparations mainly based on hyaluronic acid for treatments, namely, injectable for intradermal and subcutaneous application for facial and body skin tightening and smoothing; botulinum toxin for medical use for use in the treatment of excessive sweating, excessive eye blinking, neuropathy pain, facial wrinkles, headache, pain, spasm, dystonia, urogenital system diseases and conditions, skin disorders; therapeutic drugs and agents for use in the treatment of excessive sweating, excessive eye blinking, neuropathy pain, facial wrinkles, headache, pain, spasm, dystonia, urogenital system diseases and conditions, skin disorders
Case File Event Statements
  • 9/4/2019 - 6 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 8/22/2019 - 6 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR
  • 8/26/2019 - 6 years ago
    2 - LIMITATION FROM ORIGINAL APPLICATION ENTERED Type: LIMI
  • 9/4/2019 - 6 years ago
    3 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 9/5/2019 - 6 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 9/6/2019 - 6 years ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 9/10/2019 - 6 years ago
    7 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 9/16/2019 - 6 years ago
    8 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 9/16/2019 - 6 years ago
    9 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 10/5/2019 - 6 years ago
    10 - REFUSAL PROCESSED BY IB Type: RFNT
  • 3/12/2020 - 5 years ago
    11 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 3/12/2020 - 5 years ago
    12 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 3/12/2020 - 5 years ago
    13 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 3/12/2020 - 5 years ago
    14 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 3/26/2020 - 5 years ago
    15 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 4/22/2020 - 5 years ago
    16 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 5/12/2020 - 5 years ago
    17 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 5/12/2020 - 5 years ago
    18 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 7/6/2020 - 5 years ago
    19 - WITHDRAWN FROM ISSUE - MANAGING ATTORNEY REQUEST Type: ISMR
  • 7/22/2020 - 5 years ago
    20 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 7/22/2020 - 5 years ago
    21 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R
  • 7/22/2020 - 5 years ago
    22 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 8/7/2020 - 5 years ago
    23 - NOTIFICATION PROCESSED BY IB Type: GPNX
  • 8/11/2020 - 5 years ago
    24 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 8/11/2020 - 5 years ago
    25 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 10/27/2020 - 5 years ago
    26 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 2/27/2021 - 4 years ago
    30 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP
  • 3/7/2021 - 4 years ago
    31 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO
  • 1/27/2021 - 5 years ago
    27 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 2/6/2021 - 5 years ago
    28 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 2/6/2021 - 5 years ago
    29 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 3/17/2024 - a year ago
    32 - CORRECTION TRANSACTION RECEIVED FROM IB Type: CRCV
  • 4/11/2024 - a year ago
    33 - CORRECTION UNDER SECTION 7 - PROCESSED Type: COC.
  • 4/12/2024 - a year ago
    34 - CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED Type: CORR
  • 12/12/2024 - a year ago
    36 - PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED Type: INPR
  • 5/21/2024 - a year ago
    35 - NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED Type: NURC
  • 2/21/2025 - 12 months ago
    38 - CHANGE OF NAME/ADDRESS REC'D FROM IB Type: ADCH
  • 2/5/2025 - a year ago
    37 - INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE Type: INNA